Macrophage inflammatory protein-1 (MIP-1 ) is a member of the CC chemokines. We have previously reported the use of a whole bone marrow culture system to show that MIP-1 stimulates the formation of osteoclastlike multinucleated cells. Here we use rat bone marrow cells deprived of stromal cells, and clones obtained from murine macrophage-like cell line RAW264 to show that MIP-1 acts directly on cells in osteoclast lineage. We obtained several types of RAW264 cell clones, one of these clones, designated as RAW264 cell D clone (D clone), showed an extremely high response to receptor activator of NF B ligand (RANKL) and tumor necrosis factor-(TNF-), while the other clone, RAW264 cell N clone (N clone), demonstrated no response to RANKL or TNF-. Although both clones expressed receptor activator NF B (RANK) before being stimulated for differentiation, only the D clone expressed cathepsin K when cells were stimulated to differentiate to osteoclasts. MIP-1 stimulated the formation of mononuclear preosteoclastlike cells from rat bone marrow cells deprived of stromal cells. MIP-1 also stimulated formation of osteoclast-like multinucleated cells from the D clone, when these cells were stimulated with RANKL and TNF-. These findings provide strong evidence to show that MIP-1 acts directly on cells in the osteoclast lineage to stimulate osteoclastogenesis. Furthermore, pretreatment of RAW264 cell D clone with MIP-1 significantly induced adhesion properties of these cells to primary osteoblasts, suggesting a crucial role for MIP-1 in the regulation of the interaction between osteoclast precursors and osteoblasts in osteoclastogenesis.
Introduction
Chemokines, a family of the small cytokines, are known to be chemotactic factors against various types of white blood cells. Each chemokine has four conserved cystein residues and they can be classified into four types: C chemokines, CC chemokines, CXC chemokines and CXXXC chemokines; the classification depends on the number of amino acids between the first and the second cystein residue. Macrophage inflammatory protein-1 (MIP-1 ) (Nakao et al. 1990 ), a member of the CC chemokines, has chemotactic activity against monocytes, lymphocytes, dendritic cells, eosinophils, and natural killer cells (Cook et al. 1995 , Lukacs et al. 1996 , Shimada et al. 1998 , McDyer et al. 1999 , Inngjerdingen et al. 2001 ). This cytokine was also shown to be involved in the regulation of growth and differentiation of hematopoietic cells (Shiozaki et al. 1992 , Broxmeyer et al. 1993 . Neote et al. (1993) identified MIP-1 receptor as a G-protein-coupled receptor with seven transmembrane domains.
Osteoclasts are multinucleated giant cells which resorb bone. These cells are hematopoietic in origin and mononuclear precursors of osteoclasts fuse to each other to form multinucleated osteoclasts. We have previously used in situ hybridization to demonstrate the expression of MIP-1 in human normal bone tissues (Kukita et al. 1997) . We have also used a rat bone marrow culture system to show that MIP-1 induces the formation of osteoclast-like multinucleated cells (Kukita et al. 1997) . Choi et al. (2000) and Han et al. (2001) reported that MIP-1 is involved in osteoclastogenesis associated with multiple myeloma. However, it remains unclear whether MIP-1 acts directly on cells in the osteoclast lineage or acts indirectly via bone marrow stromal cells.
RAW264 cells are known to have characteristics of murine macrophages with the ability to differentiate into osteoclast-like cells by receptor activator of NF B ligand (RANKL) stimulation (Hsu et al. 1999) . The use of cell lines of osteoclast precursors provides numerous advantages for studies on the mechanism of osteoclast differentiation at a molecular level. Here we isolated novel clones with a highly efficient ability to form osteoclasts from RAW264 cells and examined their ability to respond to MIP-1 . We further examined how MIP-1 modulated the binding properties of osteoclast precursors to osteoblasts. This study focused on clarifying the direct action of MIP-1 on cells in the osteoclast lineage.
Materials and Methods

Materials
Bone marrow cells were obtained from the tibia and femur of 4-week-old male Sprague-Dawley rats. Bone marrow stromal cells were depleted by the use of a Sephadex G10 column as described previously (Kukita et al. 1993b) . These cells were cultured in 24-multiwell plates (1 10 6 cells/well) for 4 days in -modified Eagle's medium ( -MEM) containing 15% fetal calf serum (FCS) and 10 8 M 1 ,25-dihydroxycholrecarciferol (1 ,25(OH) 2 D 3 ) and 10% (v/v) heat-treated ROS17/2·8-cell-conditioned medium (Kukita et al. 1993a) .
Culture conditions for forming osteoclast-like multinucleated cells from RAW264 cells
RAW264 cells were cultured in -MEM containing 10% FCS (3·5 10 4 cells in 500 µl/well for 24-multiwell culture plates or 6·8 10 3 cells in 150 µl/well for 96-multiwell plates) for 3 days in the presence of various concentrations of soluble RANKL and TNF-with various concentrations of MIP-1 .
Primary culture of osteoblasts and adhesion experiments
Primary osteoblasts were obtained from calvaria of 2-dayold Sprague-Dawley rats and cultured as described previously (Kukita et al. 1993b) . Cells were cultured in -MEM containing 10% FCS. he cell suspension of the D clone was seeded on the confluent culture of primary osteoblasts. After 3-6 h incubation at 37 C, cultures were washed with PBS to remove non-adherent cells and were then stained for TRAP.
Cloning of RAW264 cells
Before isolating RAW264 cell clones, the culture condition was determined by optimizing the concentrations of cytokines to form a large number of osteoclast-like cells from the original RAW264 cells. Combinations of 20-100 ng/ml RANKL and 1 ng/ml TNF-provided the most suitable conditions for osteoclastogenesis. The limiting dilution of RAW264 cell suspension was established by use of a standard protocol followed by culture for 10-14 days to form colonies. The ability to induce osteoclastogenesis was assessed for each clone by checking the ability to form osteoclast-like cells. Cells from each clone were cultured in the presence of 20 ng/ml RANKL and 1 ng/ml TNF-for 3 days, followed by staining for TRAP. Cloning of the cells was repeated twice for each clone.
Reverse transcriptase (RT-PCR)
Total RNA was extracted using a commercial kit (ISOGEN Nippongene, Toyama, Japan). First-stranded cDNA was synthesized from 1 µg total RNA and was subjected to PCR using a RT-PCR kit (Takara, Japan) and PCR system (Gene Amp model 9700). PCR primers for murine RANK were TTAAGCCAGTGCTTCA CGGG (upstream primer) and ACGTAGACCACGAT GATGTCGC (downstream primer), which produced PCR products of 497 bp. PCR primers for murine GAPDH were ACCACAGTCCATGCCATCAC (upstream primer) and TCCACCACCCTGTTGCTGTA (downstream primer), which gave PCR products of 452 bp. In PCR, annealing was performed at 55 C for 30 s and primer extension was done at 72 C for 1 min. After 30 cycles of the reaction, PCR products were separated on a 2% agarose gel and stained with ethidium bromide. Northern blotting analysis was performed according to a standard protocol. Briefly, total RNA was applied to 1·2% agarose-formaldehyde gel (10 µg/lane) and electrophoresis was performed in 20 mM 3-(N-morpholino) propanesulfonic acid (MOPS) buffer (pH 7·0) containing 8 mM sodium acetate and 1 mM EDTA. After gel electrophoresis, RNA was blotted onto the Hybond-N + nylon membrane sheet (Boehringer Mannheim). This sheet was prehybridized in DIG Easy Hyb (Boehringer Mannheim) at 65 C for 30 min and hybridized with DIG-labeled murine cathepsin K probe at 65 C overnight. After washing twice in 2 SSC containing 0·1% SDS (room temperature, each wash 5 min) and twice in 0·5 SSC containing 0·1% SDS (68 C, each wash 20 min), the membrane was treated with blocking solution for 30 min at room temprature. The hybridization signal was detected by use of anti-DIG antibody and CDP-star system (Boehringer Mannheim).
Statistical analysis
The number of TRAP-positive cells was counted and each value was represented as the mean S.E.M. of quadruplicate cultures of 24-multiwell plates. All data obtained from bone marrow cultures were analyzed using Student's t-test and a post-ANOVA test.
Results
Isolation of several types of RAW264 cell clones with different potentials for osteoclastogenesis
In cultures of RAW264 cells, significant heterogeneity of the cell population was noticed when these cells were cultured for the formation of osteoclast-like cells. In these cultures, colonies of TRAP-positive cells were frequently observed (data not shown). This observation strongly suggested the presence of several clones with different potentials for osteoclastogenesis in the conditions stimulated by the differentiation factors. Therefore, we began separating clones with different potentials for osteoclastogenesis from the original RAW264 cells by cloning these cells using a standard limiting dilution technique.
We examined 36 clones with regard to their ability to form osteoclast-like cells. These clones were grouped into four categories with respect to their potential for osteoclastogenesis, as shown in Table 1 Northern blotting analysis showed that a significant expression of cathepsin K mRNA was detected in the D clone when stimulated with RANKL and TNF-, while no expression of this mRNA was detected in the N clone treated with these cytokines (Fig. 5) . We also comfirmed that osteoclast-like MNCs formed from the D clone resorbed dentin (data not shown). We further examined the expression of RANK, the receptor for RANKL, in these clones before they were stimulated with RANKL and TNF-. Semiquantitative RT-PCR analysis showed that both clones (D and N) expressed RANK at least by RNA (Fig. 6 ). These data suggest that the remarkable difference between the D clone and the N clone in their potentials for osteoclastogenesis is not a result of differences in RANK expression. These findings demonstrate the usefulness of the D clone for studies on the molecular mechanisms of osteoclastogenesis.
MIP-1 stimulates formation of preosteoclasts from bone marrow cells deprived of stromal cells
We reported previously that MIP-1 stimulates osteoclastogenesis in a rat whole bone marrow culture system maximal stimulation was observed at 1-2 ng/ml MIP-1 . We further examined whether the type II clone responded to MIP-1 . Osteoclastogenesis was also significantly stimulated by 2-6 ng/ml MIP-1 in the type II RAW264 clone (Table 3) . These results provide strong evidence to show that MIP-1 acts directly on cells in the osteoclast lineage to stimulate osteoclastogenesis. We also confirmed the cathepsin K mRNA expression formed in osteoclastlike cells in the presence of MIP-1 , as shown in Fig. 5 (lane 5).
MIP-1 stimulates fusion among osteoclast-like MNCs formed from the D clone
MIP-1 markedly stimulated the formation of osteoclastlike MNCs (Fig. 8) , however, higher concentrations of MIP-1 tended to suppress the number of MNCs formed in these cultures. This apparently suppressive effect of high doses of MIP-1 could be attributed to stimulation of fusion among osteoclast-like MNCs. Therefore, we examined this possibility by creating a histogram in which the relation between MIP-1 dose and the degree of multinucleation was assessed, as shown in Fig. 9 . Higher concentrations of MIP-1 significantly stimulated formation of MNCs with a large number of nuclei of greater than 41 nuclei per osteoclast-like MNC. These findings strongly suggest that the apparent decrease in the number of osteoclast-like MNCs formed in the presence of 10 ng/ ml of MIP-1 (Fig. 8) is a result of stimulation of fusion in osteoclast-like MNCs.
MIP-1 -induced adhesion of the D clone to primary osteoblasts
The adhesion of osteoclast precursors to osteoblasts is an important step in the regulation of osteoclastogenesis. Therefore, we further investigated whether MIP-1 modulates the adhesion properties of the D clone to primary osteoblasts. As shown in Fig. 10 , the MIP-1 -treated D clone adhered efficiently to primary osteoblasts in comparison with untreated D clones. These results Cells of the D clone were cultured in 96-multiwell plates to form osteoclast-like MNCs (4·5 10 4 cells/ml, 150 l/well) in the presence of 20 ng/ml RANKL and 1 ng/ml TNF-. Various concentrations of MIP-1 were added. MIP-1 (0·5-4 ng/ml) significantly stimulated formation of TRAP-positive MNCs in a dose-dependent manner. *P<0·05; **P<0·01. Data represent a typical experiment for three independent experiments. Cells of type II clone were cultured in 96-multiwell plates (4·5 10 4 cells/ml, 150 l/well) to form osteoclast-like MNCs in the presence of 20 ng/ml RANKL and 1 ng/ml TNF-. Various concentrations of MIP-1 were added. MIP-1 significantly stimulated the formation of TRAP-positive MNCs at concentrations of 2-6 ng/ml. *P<0·05. Data represent a typical experiment for three independent experiments. TOSHIYUKI WATANABE and others · MIP-1 directly stimulates osteoclastogenesissuggest that MIP-1 induces expression of adhesion molecules on the cell surface of the D clone. Previously, we reported that lymphocyte function-associated antigen-1 (LFA1) is expressed on mononuclear precursors of rat osteoclasts and that this molecule participates in the regulation of osteoclastogenesis (Harada et al. 1998) . Therefore, expression of LFA1 and on the surface of the D clones was examined by use of specific antibodies. Both molecules were expressed on the cell surface of the D clone, however, the level of the expression was not altered when these cells were treated with MIP-1 (data not shown).
Discussion
The macrophage-like cell line RAW264 is useful for studying osteoclastogenesis. The D clone used in the present study, is able to differentiate into osteoclast-like MNCs at a very high rate even at low concentrations of RANKL, while the N clone has no ability to differentiate into osteoclast-like cells. Although these two types of clones were derived from the same origin, sensitivity to RANKL differed between these clones. We also obtained other types of clones that had intermediate potentials for osteoclastogenesis. One type of clone differentiated into TRAP-positive MNCs, however, their number of nuclei was limited to 3-5 per cell. Another type of clone differentiated into mononuclear TRAP-positive preosteoclast-like cells, but they never fused to each other to form MNCs. These four types of RAW264 cell clones are suggested to be suitable for molecular analysis of osteoclastogenesis involving signal transduction studies. They will be of value for studies of the molecular mechanisms of osteoclast differentiation, to isolate and maintain stable RAW264 cell clones with different responses against differentiation stimuli. RT-PCR analysis and Northern blotting analysis showed that both the D clone and the N clone expressed significant levels of RANK, the receptor for RANKL, but that only the D clone expressed cathepsin K after being stimulated for osteoclastogenesis. Anderson et al. (1997) stated that RANK mRNA levels do not accurately predict RANK protein expression on the cell surface. It is true that there is a limitation of using RANK mRNA to predict RANKL responsiveness and the potentiation of the MIP-1 signal; further analysis is required in respect of the RANK protein expression on the cell surface of RAW264 cell clones. However, the current data may suggest that the N clone has some defects in the signaling pathway, downstream of RANK, that leads to the expression of molecules required for osteoclastogenesis. The D clone, N clone and other clones obtained in this study would provide powerful tools for molecular biological analysis of osteoclast differentiation.
We have previously reported that MIP-1 participates in osteoclast formation in rat whole bone marrow cultures (Kukita et al. 1992 (Kukita et al. , 1997 . We have also reported that MIP-1 is expressed in human osteoblasts and that this chemokine induces osteoclast formation on dentin slices. However it has not yet been clear whether MIP-1 acts directly on cells in the osteoclast lineage or not. The current study demonstrates that MIP-1 acted directly on cells in the osteoclast lineage and induced differentiation in culture systems in which other types of cells were not involved. One of the culture systems used was the stromal cell-deprived bone marrow culture system for forming mononuclear preosteoclast-like cells. The other culture system used was the pure culture system in which only a particular RAW264 cell clone was involved. As MIP-1 showed stimulation of osteoclastogenesis in both culture systems, it is concluded that MIP-1 directly acts on cells in the osteoclast lineage to augment formation of osteoclast-like cells. Han et al. (2001) recently reported that CC-chemokine receptor (CCR1) and CCR5 are involved in MIP-1 -induced osteoclastogenesis in culture systems of bone marrow cells from patients with multiple myeloma. In our culture systems for osteoclastogenesis induced by MIP-1 , these chemokine receptors are supposed to play an important role in the stimulation of osteoclastogenesis. Our culture system using the D clone would provide a suitable system for investigating signal transduction mediated by MIP-1 in osteoclastogenesis. In osteoclast differentiation induced by RANKL, signal transduction through TNF receptor-associated factor 6 (TRAF6) is important (Kobayashi et al. 2001) . As stimulation of osteoclastogenesis by MIP-1 was only observed when cells were treated with RANKL, it is supposed that MIP-1 could modulate the TRAF6 signaling pathway triggered by RANKL. These studies are underway in our laboratories.
Adhesion of osteoclast progenitors to osteoblasts has been recognized as an essential step for osteoclastogenesis (Takahashi et al. 1988 , Tanaka et al. 1998b . Here it has been demonstrated that MIP-1 dramatically enhances adhesion of the D clone to the monolayer of primary osteoblasts. The differentiated D clone expressed significant levels of LFA-1 and , however, the level of the expression of these molecules was not altered by the addition of MIP-1 (data not shown). We can not rule out the possibility that MIP-1 activates an inactive-form of LFA-1 integrin (Pruijt et al. 1998 , Tanaka et al. 1998a , Fibbe et al. 1999 into an active form and that such activation of LFA-1 induces a marked increase in adhesion of the D clone to osteoblasts. Intercellular adhesion molecule-1 (ICAM-1), the ligand for LFA-1 integrin is known to be expressed on the cell surface of osteoblasts (Kurachi et al. 1993) , therefore, activation of LFA-1 on the cell surface of the D clone may result in a marked increase in the cell adhesion of the D clone to the monolayer of the osteoblasts. Alternatively, we can not rule out the possibility that expression of other cell adhesion molecules was induced by treatment of the D clone with MIP-1 . Further studies are required to elucidate the mechanism explaining the marked stimulation of the adhesion between MIP-1 -treated RAW264 cell D clone and osteoblasts. It is thought that MIP-1 produced by the osteoblasts acts as a chemotactic factor against osteoclast progenitor cells at an early step of osteoclastogenesis through CCR1 or CCR5. This process is thought to involve activation of some integrin, e.g. LFA1. Activated LFA1 could bind to ICAM-1 expressed on the cell surface of osteoblasts. Such interactions would facilitate the tight adhesion of osteoclast progenitors to osteoblasts, allowing these progenitors to be effectively exposed to RANKL and MIP-1 produced by osteoblasts. Thus osteoclast progenitors accumulated on the cell surface of osteoblasts would differentiate into real osteoclast precursors. At the subsequent fusion process, MIP-1 produced by osteoblasts will act to augment cell fusion. Thus it is supposed that MIP-1 acts as the upregulator of osteoclastogenesis in bone.
Figure 10
Induction of osteoblast adhesion in the D clone by treatment with MIP-1 . Primary osteoblasts were obtained and cultured to be confluent as described in Materials and Methods. The D clone was cultured for 2 days in the presence of 20 ng/ml RANKL and 1 ng/ml TNF-with or without 1 ng/ml of MIP-1 ; it was then washed and replated on the monolayers of primary osteoblasts. After 3 and 6 h incubation in the absence of MIP-1 , non-adherent cells were removed by rinsing in -MEM followed by staining for TRAP. The number of adherent TRAP-positive cells were counted. Marked stimulation of cell adhesion was induced by a treatment of the D clone with 1 ng/ml MIP-1 . **P,0·01, ***P,0·001. Data represent a typical experiment for three independent experiments.
The use of a combination of RAW264 cell clones with different potentials for osteoclastogenesis could provide a powerful tool for clarifying the genes and their products that are essential for each stage of the osteoclast differentiation. This work is now underway in our laboratories.
